Archive for the ‘Patient Adherence’ Category

Get to know the newest MEMOTEXT team member

Milind Parate Chief Financial Officer & Investor Relations   Milind joins MEMOTEXT with more than 16 years on Wall Street where he covered the healthcare sector across investment banking (M&A, corporate finance, capital markets, investor relations) and equity research. He has split his time between the therapeutics and healthcare services/HCIT verticals.   Q. Why did

READ MORE

MEMOTEXT announces collaboration with Mass General to create a digital health intervention for parents of children with ADHD

MEMOTEXT, a company specializing in developing and delivering personalized digital health interventions, today announced a collaboration with Massachusetts General Hospital (MGH) to   create a text-messaging-based program that can help address the issue of medication adherence in  children with attention deficit /hyperactivity disorder (ADHD).  The collaboration aims to advance and make available to patients and families

READ MORE

Join our newly formed Value-Based Digital Health Working Group

There is much talk about the need to embrace digital health solutions as one of the key strategies needed to successfully compete in a transformed value-driven healthcare delivery environment but what are the detailed mechanisms by which we can facilitate this change. In this working-group we want to define the success metrics in greater detail

READ MORE

UBC and MEMOTEXT collaborate on a support text message program for pregnant women in B.C.

Optimal Birth BC, a partnership between academic researchers from UBC and provincial health authorities, have launched a research program to examine the effectiveness and scalability of a prenatal education program delivered by text messaging for expectant women in BC.  The study will include all pregnant women with a specific focus on increasing accessibility to women

READ MORE

MEMOTEXT, STI and Allergan launch integrated Restasis® digital patient support program

Allergan Inc. has partnered with STI Technologies Limited and MEMOTEXT to launch the Restasis® treatment support pilot program: a digital health patient adherence and support program aimed at improving medication adherence for patients with dry eye. The pilot program was first launched in the province of Ontario and has recently been expanded to include the

READ MORE

The Hard Truth of Patient Engagement: Realizations from Stanford’s MedicineX…

I’ve now recovered from my #MedXhangover. The term commonly used to refer to the general malaise that the majority of attendees experience once they return to real-life after spending three days living within the confines of Stanford MedicineX (MedX) community. MedX is not your average run-of-the-mill healthcare conference. MedX is different. It tries and succeeds

READ MORE

HPTN and MEMOTEXT collaborate on integrated care communications platform

The HIV Prevention Trials Network (HPTN) has launched a research study examining the feasibility and scalability of an integrated, enhanced, case manager care strategy to attain and maintain viral suppression among HIV-infected men who have sex with men (MSM) in the United States. The study is being conducted in four US cities with 356 participants

READ MORE

MEMOTEXT @MedX: Using personalized digital health behavior change to manage asthma

  MEMOTEXT is returning to Stanford MedX!  On Sunday September 18 @ 11:00AM come and visit us in the lower lobby. We will be presenting our poster entitled: Using personalized digital health behavior change to manage asthma.Check out our abstract below and hopefully we’ll see you there!  If you can’t make it, let us know. We’ll

READ MORE

CAMH and MEMOTEXT Launch Collaborative Venture

CAMH and MEMOTEXT sign MOU to co-develop mobile health intervention for schizophrenia (TORONTO) May 11, 2016 – The Centre for Addiction and Mental Health (CAMH) and MEMOTEXT Corporation have signed a memorandum of understanding (MOU) to develop and commercialize an award-winning mobile health intervention for people with schizophrenia. The app will engage patients more fully

READ MORE

BAM! A new framework for measuring adherence goes live at the PQA.

Today, we presented an update to our Balanced Adherence Metric at the PQA Annual Meeting & Innovation Forum in Arlington, VA. Objectively evaluating adherence is difficult.  Beyond checking blood levels of the medication in question, assessments are limited to proxy measures.  These measures have varying degrees of error and reliability.  Due to its relative availability,

READ MORE
Back to Top